Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors. (Record no. 10280399)

MARC details
000 -LEADER
fixed length control field 01659 a2200505 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20250513182650.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 199905s 0 0 eng d
022 ## - INTERNATIONAL STANDARD SERIAL NUMBER
International Standard Serial Number 0344-5704
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/s002800050928
Source of number or code doi
040 ## - CATALOGING SOURCE
Original cataloging agency NLM
Language of cataloging eng
Transcribing agency NLM
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Koda, R T
264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE
Date of production, publication, distribution, manufacture, or copyright notice 19990520
245 00 - TITLE STATEMENT
Title Phase I study of AG 331, a novel thymidylate synthase inhibitor, in patients with refractory solid tumors.
Medium [electronic resource]
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Name of publisher, distributor, etc. Cancer chemotherapy and pharmacology
Date of publication, distribution, etc. 1999
300 ## - PHYSICAL DESCRIPTION
Extent 489-96 p.
Other physical details digital
500 ## - GENERAL NOTE
General note Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article; Research Support, Non-U.S. Gov't
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Adult
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Antimetabolites, Antineoplastic
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Dose-Response Relationship, Drug
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Enzyme Inhibitors
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Female
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Half-Life
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Humans
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Indoles
General subdivision adverse effects
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Male
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Middle Aged
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Neoplasms
General subdivision drug therapy
650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Thymidylate Synthase
General subdivision antagonists & inhibitors
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Garcia, A A
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Chatterjee, D J
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Li, W Y
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Parimoo, D
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Jeffers, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Rogers, M
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Leichman, C G
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Leichman, L
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Wu, E Y
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Shetty, B V
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Webber, S
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Clendinnin, N
700 1# - ADDED ENTRY--PERSONAL NAME
Personal name Muggia, F M
773 0# - HOST ITEM ENTRY
Title Cancer chemotherapy and pharmacology
Related parts vol. 43
-- no. 6
-- p. 489-96
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="https://doi.org/10.1007/s002800050928">https://doi.org/10.1007/s002800050928</a>
Public note Available from publisher's website

No items available.